Status:

COMPLETED

Screening and Evaluation of Patients With Signs and Symptoms of Alzheimer's Disease

Lead Sponsor:

National Institute of Mental Health (NIMH)

Conditions:

Alzheimer's Disease

Eligibility:

All Genders

45+ years

Brief Summary

Background: * Individuals who demonstrate symptoms of Alzheimer s disease, such as progressive memory loss, may be eligible to participate in National Institutes of Health research studies. However, ...

Detailed Description

Objective: To provide a mechanism for recruitment and screening of AD patients for inclusion into studies conducted at the National Institutes of Health. To provide data from MRI and \[18F\]FDG and PI...

Eligibility Criteria

Inclusion

  • Patients with signs and symptoms of Alzheimer s disease will be recruited from neurological and psychiatric clinics, from self or family referral in response to advertisements or from private physicians. Healthy volunteers will be recruited by the MIB.
  • INCLUSION CRITERIA:
  • Patients and healthy volunteers must be age 45 or older.
  • Patients must have a history of progressive memory impairment.
  • Patients must have a caregiver who is willing to accompany the subject to the NIH.
  • EXCLUSION CRITERIA FOR PATIENTS:
  • The diagnosis of a different type of dementia, including frontotemporal dementia, normal pressure hydrocephalus, Lewy body dementia, Parkinson s disease dementia, Huntington s disease, or vascular dementia.
  • Pregnant women. Women of childbearing potential will be screened by history for the possibility of pregnancy and undergo a urine pregnancy test.
  • Any medical contraindication to the procedures performed in the study, or any current severe medical or psychiatric illness other than Alzheimer s disease.
  • Behavioral symptoms that would preclude the gathering of data for the study, or advanced disease such that subjects cannot provide assent.
  • EXCLUSION CRITERIA FOR CONTROLS:
  • The diagnosis of a brain disorder.
  • Pregnant women.
  • Any medical contraindication to the procedures performed in the study, or any current severe medical or psychiatric illness.

Exclusion

    Key Trial Info

    Start Date :

    July 31 2009

    Trial Type :

    OBSERVATIONAL

    Allocation :

    ACTUAL

    End Date :

    July 6 2017

    Estimated Enrollment :

    197 Patients enrolled

    Trial Details

    Trial ID

    NCT00955422

    Start Date

    July 31 2009

    End Date

    July 6 2017

    Last Update

    July 5 2018

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    National Institutes of Health Clinical Center, 9000 Rockville Pike

    Bethesda, Maryland, United States, 20892

    Screening and Evaluation of Patients With Signs and Symptoms of Alzheimer's Disease | DecenTrialz